Connor, Clark & Lunn Investment Management (CC&L)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.49M | Sell |
|
|||||
|
2025
Q2 | $5.13M | Buy |
|
|||||
|
2025
Q1 | $4.26M | Buy |
|
|||||
|
2024
Q4 | $832K | Sell |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.11M | Sell |
|
|||||
|
2023
Q1 | $1.71M | Buy |
|
|||||
|
2022
Q4 | $617K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $502K | Sell |
|
|||||
|
2021
Q4 | $511K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $417K | Buy |
|